LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 6.21 | 21.74 | 836 | 392 | 2.1327 | 1.3981 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 8.19 | 21.74 | 6 | 439 | 0.0136 | -0.2568 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 8.19 | 21.74 | 841 | 439 | 1.9120 | 1.3222 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 8.19 | 21.74 | 32 | 439 | 0.0728 | 0.0932 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 8.19 | 21.74 | 903 | 439 | 2.0529 | 1.3606 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 10.16 | 21.74 | 26 | 463 | 0.0561 | 0.0414 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 10.16 | 21.74 | 887 | 463 | 1.9131 | 1.3166 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 10.16 | 21.74 | 90 | 463 | 0.1941 | 0.3796 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 10.16 | 21.74 | 951 | 463 | 2.0511 | 1.3534 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.13 | 21.74 | 59 | 496 | 0.1189 | 0.2476 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.13 | 21.74 | 910 | 496 | 1.8334 | 1.2875 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.13 | 21.74 | 176 | 496 | 0.3546 | 0.5895 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.13 | 21.74 | 997 | 496 | 2.0086 | 1.3343 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.10 | 21.74 | 98 | 540 | 0.1812 | 0.3837 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.10 | 21.74 | 945 | 540 | 1.7470 | 1.2557 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.10 | 21.74 | 280 | 540 | 0.5176 | 0.7352 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.10 | 21.74 | 1017 | 540 | 1.8801 | 1.2917 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.07 | 21.74 | 139 | 597 | 0.2325 | 0.4741 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.07 | 21.74 | 946 | 597 | 1.5823 | 1.2015 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.07 | 21.74 | 338 | 597 | 0.5654 | 0.7751 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 16.07 | 21.74 | 1032 | 597 | 1.7262 | 1.2419 | MN20160310_N01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.04 | 21.74 | 304 | 750 | 0.4050 | 0.6758 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.04 | 21.74 | 964 | 750 | 1.2844 | 1.1004 | MN20160310_N01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 18.04 | 21.74 | 644 | 750 | 0.8580 | 0.9410 | MN20160310_N01 | G04 |